![](/img/cover-not-exists.png)
Randomized Phase II trial of nintedanib, afatinib and sequential combination in castration-resistant prostate cancer
Molife, L Rhoda, Omlin, Aurelius, Jones, Rob J, Karavasilis, Vasilios, Bloomfield, David, Lumsden, Graeme, Fong, Peter C, Olmos, David, O‘Sullivan, Joe M, Pedley, Ian, Hickish, Tamas, Jenkins, Peter,Volume:
10
Language:
english
Journal:
Future Oncology
DOI:
10.2217/fon.13.250
Date:
February, 2014
File:
PDF, 2.55 MB
english, 2014